Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System). Issue 6 (6th February 2018) - Tjong, Fleur V.Y.; Knops, Reinoud E.; Neuzil, Petr; Petru, Jan; Sediva, Lucie; Wilde, Arthur A.M.; Sperzel, Johannes; Reddy, Vivek Y.